EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Adjunctive Remotely Supervised tDCS in Multiple Sclerosis: A GRADE-Assessed Meta-analysis of Sham-Controlled Trials on Cognitive, Fatigue, Mobility, and Quality-of-Life Outcomes

Omar Khaled Abdelsalam, Mousa Almasalma, Ali Nagy Shelbaya, Ahmed Raja Albishti, Mohamed H. Khalil, Hamza Khelifa, Ahmed Abdelsalam, Asmaa Zakria Alnajjar

ASIDE Internal Medicine · 25.04.2026 · 2 (3) · 55-64

DOI: 10.71079/aside.im.042526637 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift ASIDE Internal Medicine, online erschienen am 25.04.2026. Verfasst von Omar Khaled Abdelsalam und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple sclerosis (MS) is an immune-mediated disorder characterized by demyelination within the central nervous system, resulting in fatigue, pain, cognitive dysfunction, and motor impairment. Remotely supervised transcranial direct current stimulation (RS‑tDCS) is a noninvasive, low-cost, home-based intervention that modulates neuronal excitability and enhances neural network function, potentially benefiting individuals with MS. This meta-analysis aimed to evaluate the efficacy of RS‑tDCS in MS.

Methods

A systematic search was conducted in PubMed, Web of Science, Scopus, and the Cochrane Library for randomized controlled trials (RCTs) evaluating RS‑tDCS in MS. The primary outcome was information‑processing speed. Statistical analyses were performed using R software (version 4.5.0) and a random‑effects model to calculate pooled standardized mean differences (SMDs) and mean differences (MDs) with 95% confidence intervals (CIs). Risk of bias was assessed using the Cochrane ROB‑2 tool.

Results

Five RCTs, most featuring co-interventions alongside RS-tDCS in both study arms and one specifically targeting MS patients with cannabis use disorder, including 291 participants, were analyzed. Active RS‑tDCS did not significantly improve information‑processing speed (SMD = 0.20; 95% CI: –0.06 to 0.45; P = 0.13, n studies: 4). No significant effects were observed for secondary outcomes.

Conclusion

Evidence from five heterogeneous RCTs, predominantly featuring co-interventions, shows no clear benefit of RS-tDCS for MS cognitive or functional outcomes (very low to low certainty). This highlights substantial uncertainty; larger standalone trials are required.

Zitieren

APA

Abdelsalam, O. K., Almasalma, M., Shelbaya, A. N., Albishti, A. R., Khalil, M. H., Khelifa, H., Abdelsalam, A., & Alnajjar, A. Z. (2026). Adjunctive Remotely Supervised tDCS in Multiple Sclerosis: A GRADE-Assessed Meta-analysis of Sham-Controlled Trials on Cognitive, Fatigue, Mobility, and Quality-of-Life Outcomes. ASIDE Internal Medicine, 2(3), 55-64. https://doi.org/10.71079/aside.im.042526637

Vancouver

Abdelsalam OK, Almasalma M, Shelbaya AN, Albishti AR, Khalil MH, Khelifa H, et al. Adjunctive Remotely Supervised tDCS in Multiple Sclerosis: A GRADE-Assessed Meta-analysis of Sham-Controlled Trials on Cognitive, Fatigue, Mobility, and Quality-of-Life Outcomes. ASIDE Internal Medicine. 2026;2(3):55-64. doi:10.71079/aside.im.042526637

BibTeX
@article{Abdelsalam2026,
  author = {Abdelsalam, Omar Khaled and Almasalma, Mousa and Shelbaya, Ali Nagy and Albishti, Ahmed Raja and Khalil, Mohamed H. and Khelifa, Hamza and Abdelsalam, Ahmed and Alnajjar, Asmaa Zakria},
  title = {Adjunctive Remotely Supervised tDCS in Multiple Sclerosis: A GRADE-Assessed Meta-analysis of Sham-Controlled Trials on Cognitive, Fatigue, Mobility, and Quality-of-Life Outcomes},
  journal = {ASIDE Internal Medicine},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {55--64},
  doi = {10.71079/aside.im.042526637}
}
Kostenlos starten →